S

Siamab Therapeutics

3 employees

Siamab Therapeutics is a biopharmaceutical company that develops therapies targeting abnormal carbohydrates found only on cancer cells.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma

Date founded

2006

Funding rounds raised

Total raised

$2.5M

from 13 investors over 13 rounds

S

Siamab Therapeutics raised $140K on March 30, 2016

Investors: Maine Angels

S

Siamab Therapeutics raised $42K on January 1, 2015

Investors: Maine Angels

S

Siamab Therapeutics raised $1.2M on February 5, 2014

Investors: Maine Angels, Desert Angels, Boston Harbor Angels Inc., Launchpad Venture Group, Mass Medical Angels and Beacon Angels

S

Siamab Therapeutics raised $2.5M on July 15, 2013

Investors: Maine Angels, Launchpad Venture Group, Boston Harbor Angels Inc. and Mass Medical Angels

S

Siamab Therapeutics raised $255K on July 1, 2013

Investors: Maine Angels

FAQ